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Sophie MS Liem1,5*, Dick J Bekedam1, Kitty WM Bloemenkamp2, Anneke Kwee3, Dimitri NM Papatsonis4,
Joris AM van der Post5, Arianne C Lim5, Hubertina CJ Scheepers6, Christine Willekes6, Johannes J Duvekot7,
Marc Spaanderman8, Martina Porath9, Jim van Eyck10, Monique C Haak11, Marielle G van Pampus12,
Hein W Bruinse3, Ben Willem J Mol5 and Maud A Hegeman1The initial sample size calculation in our protocol [1] was
based on the expected proportion of ‘bad neonatal out-
come’ in the intervention group (3.9%) and control group
(7.2%) and accounts for the fact that the outcomes in chil-
dren from multiple pregnancies are non-independent using
an intra class correlation of 0.6. As the intervention is per-
formed on the mother, analysis should be done on the ma-
ternal level. This adjustment was made during recruitment
and approved by the medical ethics committee. The sample
size is calculated based on the primary outcome 'bad neo-
natal outcome'. In the control group, 'bad neonatal out-
come' is expected in 7.2% of the children 1:8%  77%ð
þ5:4%  35%þ 7:2%  12%þ 35:6%  8%þ50%  :5%¼
7:2%Þ . In this calculation, the first rate represents the
probability that a patient delivers at that gestational age,
whereas the second rate represents the probability of 'bad
neonatal outcome' at that particular gestational age. In
case of treatment, 'bad neonatal outcome' is then
expected in 3.9% of the children 0:9%  77%þ 2:7%ð
35%þ 3:6%  12%þ 17:8%  8%þ 75%  :5% ¼ 3:9%Þ.
On the mother level this corresponds to an expected ‘bad
neonatal outcome’ in at least one of two children of 12.4%
in the control group and 6.7% in case of treatment. Using a
two-sided test with an alpha of 0.05 and a power of 0.80 we
need 400 women in the control group and 400 in the inter-
vention group.
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